Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 650x65px

News > All

Total search results: 17102 | Ordered by Source (ascending)
next pagenext page 1 2 3 4 ... 170 171 172  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
AB Sciex. (10/26/11). "Press Release: AB Sciex Advances Food Safety by Mass Spectrometry with the Industry’s First Verified Method for Allergen Testing". Framingham, MA. 2011-10-26
AB Sciex. (10/4/10). "Press Release: ETH Zurich Develops the World’s First Proteomics MRM Atlas with QTRAP Technology from AB Sciex. Online Database of Mass Spectrometry-based Assays to Accelerate Protein Analysis". Foster City, CA. 2010-10-04
AB Sciex. (11/13/14). "Press Release: Germany’s Swimming Professor Chooses AB Sciex QTRAP Technology for Ground-breaking Rhine River Water Decontamination". Darmstadt. 2014-11-13
AB Sciex. (11/8/12). "Press Release: AB Sciex, Phenomenex and Peak Scientific Take Mobile Laboratory on European MASStatic Voyage Tour. Mobile Lab Will Stop at EBF Conference in Barcelona Next Week to Demonstrate LC/MS/MS Workflows". Framingham, MA. 2012-11-08
AB Sciex. (11/8/13). "Press Release: AB Sciex’s European MASStastic Voyage Tour Brings Mobile Analytical Laboratory to Ireland’s Gathering of Leading Separation Scientists". Framingham, MA. 2013-11-08
AB Sciex. (12/8/10). "Press Release: AB Sciex Collaborates with Major German Water Supply Company to Improve Identification of Contaminants in Drinking Water. Scientists Aim to Develop New Test Methods on the AB Sciex TripleTOF 5600 System". Foster City, 2010-12-08
AB Sciex. (2/1/11). "Press Release: AB Sciex Announces the Appointment of Rainer Blair as President". Framingham, MA. 2011-02-01
AB Sciex. (2/15/11). "Press Release: The Institute of Cancer Research and AB Sciex Target the Spread of Disease Revealed through Mass Spectrometry Imaging. Collaboration to Improve and Standardize Methods for Studying Cancer Metastasis with MALDI-TOF/TOF 2011-02-15
AB Sciex. (2/3/15). "Press Release: AB Sciex Triple Quad 6500 LC/MS/MS Systems Enable New Levels of Sensitivity for Clinical Trials of Inhaled Drugs". Warrington. 2015-02-03
AB Sciex. (2/5/14). "Press Release: A Glass of Wine Could Trigger Allergies, Increasing the Need for »Wine-testing« before »Wine-tasting«. New Method from AB Sciex Identifies Milk and Egg Allergens in Wine". Framingham, MA. 2014-02-05
AB Sciex. (3/14/13). "Press Release: AB Sciex Announces 5th Berliner LC/MS/MS Symposium, April 9th, Berlin". Darmstadt. 2013-03-14
AB Sciex. (3/18/13). "Press Release: Eurofins Collaborates with AB Sciex and Phenomenex to Improve Analysis of Animal Feed. Accelerating the Development of New Methods Available to the Food Testing Community Worldwide". Des Moines, IO & Framingham, MA. 2013-03-18
AB Sciex. (3/2/10). "Press Release: AB Sciex Software Application Advances Disease Research, Drug Discovery and Biomarker Research. Company Launches Life Science Industry’s First Mass Spectrometry-based Application for Lipidomics Studies". Foster City, C 2010-03-02
AB Sciex. (3/4/10). "Press Release: AB Sciex and the University of Geneva’s Mass Spectrometry Centre Collaborate to Improve Drug Discovery and Development. Joint Efforts Focus on Creation of New Applications for Groundbreakting, High-resolution Platform" 2010-03-04
AB Sciex. (4/1/14). "Press Release: AB Sciex Announces Immunosuppressants Kit for Use by Doctors in Europe to Help Care for Organ Transplant Patients". Framingham, MA. 2014-04-01
AB Sciex. (4/1/14). "Press Release: Newborn Screening Solution from AB Sciex Provides Early Detection of Indicators of Metabolic Disorders to Help Doctors in Europe Make Babies’ Health more Predictable". Framingham, MA. 2014-04-01
AB Sciex. (4/11/12). "Press Release: AB Sciex Announces New Distribution Agreement with Cluster in Serbia and Macedonia". Serbia. 2012-04-11
AB Sciex. (4/17/12). "Press Release: Breakthrough Proteomics Technique SWATH Acquisition Is Made Availabble to the Worldwide Scientific Community. Data-independent SWATH Acquisition on the TripleTOF 5600 System Enables Comprehensive Proteome-wide Quantit 2012-04-17
AB Sciex. (5/20/13). "Press Release: AB Sciex Announces In Vitro Diagnostic Devices CE Marked for Europe. Company to Meet European Regulatory Requirements for Use in Clinical Laboratories and Hospitals". Milan. 2013-05-20
AB Sciex. (5/23/13). "Press Release: AB Sciex Improves Food Safety with New Method to Identify Markers for Horse Meat and the Banned Veterinary Drug Residue Phenylbutazone. New LC/MS/MS-based Meat Speciation Method". Warrington, UK. 2013-05-23
AB Sciex. (6/16/14). "Press Release: AB Sciex Releases New Mass Spectrometry Solutions at ASMS Conference". Framingham, MA. 2014-06-16
AB Sciex. (6/22/11). "Press Release: Aarhus University Speeds Up Target Discovery and Verification in Biomedical Research with AB Sciex TripleTOF 5600 and QTRAP 5500 Systems". Denmark. 2011-06-22
AB Sciex. (6/6/11). "Press Release: New Technique to Revolutionize Proteomics Mass Spectrometry. Next Step in Collaboration with ETH Zurich Focuses on Development of SWATH™ Acquisition on TripleTOF 5600 System to Enable Comprehensive System Proteomics". 2011-06-06
AB Sciex. (7/10/13). "Press Release: AB Sciex to Drive Innovation in Separations Science with Combination of Eksigent Chromatography with Capillary Electrophoresis from Beckman Coulter Life Sciences". 2013-07-10
AB Sciex. (7/21/10). "Press Release: AB Sciex and the ETH Zurich Institute of Molecular Systems Biology Team Up to Help Advance Systems Biology. Collaboration to Create New Methods on AB Sciex QTRAP". Foster City, CA. 2010-07-21
AB Sciex. (7/29/14). "Press Release: AB Sciex Announces the 4500MD Series for In vitro Diagnostic Use". Framingham, MA. 2014-07-29
AB Sciex. (7/31/13). "Press Release: AB Sciex Expands Clinical Solutions with New Family of In Vitro Diagnostic Reagent Kits CE Marked for Europe". Framingham, MA. 2013-07-31
AB Sciex. (9/10/12). "Press Release: AB Sciex Advances Proteomics Research with New Eksigent nanoLC System". Framingham, MA. 2012-09-10
AB Sciex. (9/30/10). "Press Release: Leading Researchers to Present Scientific Advancements at First European Conference on Mass Spectrometry Hosted by AB Sciex". Amsterdam. 2010-09-30
AB-Biotics S.A.. (10/2/13). "Press Release: AB-Biotics and Scienta Farma Partner to Sell a Pharmacogenetic Test in Mexico". Barcelona. 2013-10-02
AB-Biotics S.A.. (10/28/13). "Press Release: AB-Biotics Acquires a Patent for Predicting Antipsychotic-induced Extrapyramidal Symptoms". Barcelona. 2013-10-28
AB-Biotics S.A.. (11/7/12). "Press Release: AB-Biotics Signs Agreement with HanAll BioPharma to Distribute Its Cholesterol-lowering Probiotic in Korea". Barcelona. 2012-11-07
AB-Biotics S.A.. (2/28/12). "Press Release: AB-Biotics Sign Licensing Agreements on Cholesterol-lowering Probiotic for Southeast Europe and Spain". 2012-02-28
AB2 Bio Ltd.. (1/11/16). "Press Release: AB2 Bio Ltd Raises CHF 21 Million (USD 21 Million) in Series B Financing Round". Lausanne. 2016-01-11
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. 2018-02-15
Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. 2019-10-15
Abbott Laboratories Inc.. (10/19/11). "Press Release: Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-based Pharmaceuticals. Two Publicly Traded Companies Will Offer Shareholder Distinct Opportunities". Abbott P 2011-10-19
Abbott Laboratories Inc.. (11/28/11). "Press Release: Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen". Des Plaines, IL. 2011-11-28
Abbott Laboratories Inc.. (2/1/16). "Press Release: Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence". Abbott Park, IL & Waltham, MA. 2016-02-01
Abbott Laboratories Inc.. (3/2/12). "Press Release: Abbott’s Starlims Business Acquires Distribution Partners to Build International Presence". Abbott Park, IL. 2012-03-02
Abbott Laboratories Inc.. (3/22/10). "Press Release: Abbott Completes Acquisition of STARLIMS Technologies". Abbott Park, IL. 2010-03-22
Abbott. (1/2/13). "Press Release: Abbott Completes Separation of Research-based Pharmaceuticals Business". Abbott Park, IL. 2013-01-02
Abbott. (4/10/13). "Press Release: Abbott’s Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient". Abbott Park, IL. 2013-04-10
AbbVie Inc.. (1/25/19). "Press Release: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results". North Chicago, IL. 2019-01-25
AbbVie Inc.. (6/19/14). "Press Release: Announcement Falling Under Rule 2.4 of the City Code on Takeovers and Mergers. AbbVie Inc. Notes the Recent Press Speculation and Confirms It Made an Indicative Approach to Shire plc with a Merger Proposal which Wa 2014-06-19
AbbVie Inc.. (6/25/19). "Press Release: AbbVie to Acquire Allergan in Transformative Move for Both Companies". 2019-06-25
AbbVie Inc.. (7/18/14). "Press Release: Recommended Combination of Shire plc and AbbVie Inc. [Not for release, publication or distribution, into any jurisdiction where to do so would constitute a violation of the relevant laws or regulations]". 2014-07-18
Abcam plc. (1/21/14). "Press Release: Abcam to Open Office in Shanghai, China". Cambridge. 2014-01-21
Abcam plc. (1/21/14). "Press Release: Half Year Trading Update". Cambridge. 2014-01-21
Abcam plc. (1/21/15). "Press Release: Abcam Acquires Firefly BioWorks to Expand Capabilities in Multiplex Analysis". Cambridge. 2015-01-21
Abcam plc. (1/21/15). "Press Release: Half Year Trading Update". Cambridge. 2015-01-21
Abcam plc. (11/4/13). "Press Release: Abcam Introduces Alexa Fluor Secondary Antibodies. New Range Offers Increased Choice for Multi-colour Staining". Cambridge. 2013-11-04
Abcam plc. (3/5/12). "Press Release: Entry into Definitive Agreement to Acquire Epitomics International Inc.". 2012-03-05
Abcam plc. (4/26/18). "Press Release: Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development". Cambridge & Deqing. 2018-04-26
Abcam plc. (4/8/13). "Press Release: Abcam Licenses Novel Technology from Columbia University for Neurobiological Research". Bristol & Cambridge. 2013-04-08
Abcam plc. (5/18/17). "Press Release: Abcam Makes Final Performance-Based AxioMx Milestone Payment". Cambridge. 2017-05-18
Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. 2018-07-02
Abcam plc. (9/9/14). "Press Release: Abcam plc Announces Appointment of New CEO and Board Changes. Alan Hirzel Is Named Chief Executive Officer with Immediate Effect". Cambridge. 2014-09-09
Abcam plc. (9/9/14). "Press Release: Preliminary Results for Year Ended 30 June 2014". 2014-09-09
AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC. 2018-11-29
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
AbCellera Biologics, Inc.. (5/30/18). "Press Release: AbCellera and Harbour Antibodies Announce Technology Co-Offering Agreement for Next-Generation Fully-Human Antibody Discovery". Vancouver, BC, Rotterdam & Cambridge, MA. 2018-05-30
AbCellera Biologics, Inc.. (9/12/17). "Press Release: AbCellera Launches Antibody Discovery Collaboration with GSK". Vancouver, BC. 2017-09-12
AbCheck s.r.o.. (10/28/14). "Press Release: AbCheck Releases the AbAccel Antibody Technology for Out-licensing". Plzen. 2014-10-28
AbCheck s.r.o.. (10/5/10). "Press Release: ABCheck – Antibody Discovery Deal. First Validation of Technology and Business Approach". Plzen. 2010-10-05
AbCheck s.r.o.. (11/13/12). "Press Release: AbCheck Adds Antibody Affinity Maturation and Developability Optimization to Its Unique Phage and Yeast Display Technologies". Plzen. 2012-11-13
AbCheck s.r.o.. (2/18/13). "Press Release: AbCheck Antibody Discovery Agreement with U3 Pharma". Plzen. 2013-02-18
AbCheck s.r.o.. (4/2/14). "Press Release: AbCheck Antibody Discovery Deal with Pierre Fabre". Plzen. 2014-04-02
Abcodia Ltd.. (3/8/11). "Press Release: Collaborative Partners Sought for Abcodia, a Newly Launched Molecular Diagnostic Company". 2011-03-08
Abcodia Ltd.. (5/18/15). "Press Release: Abcodia Secures Funding of £5.25 million ($8m) to Launch the ROCA Test for the Early Detection of Ovarian Cancer". 2015-05-18
Abcodia Ltd.. (5/24/11). "Press Release: Abcodia Secures £1M Funding". 2011-05-24
Abcodia Ltd.. (6/16/11). "Press Release: Abcodia Appoints Dr Wendy Alderton as Director of Science". 2011-06-16
Abcodia Ltd.. (6/22/11). "Press Release: Abcodia Launches Colorectal Cancer Biomarker Initiative and Seeks International Collaborations". 2011-06-22
Abcodia Ltd.. (9/18/13). "Press Release: Abcodia Licenses the »Risk of Ovarian Cancer Algorithm« (ROCA) from Massachusetts General Hospital and Queen Mary, University of London". 2013-09-18
Abeona Therapeutics Inc.. (4/2/18). "Press Release: Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer". New York, NY & Cleveland, OH. 2018-04-02
Ability Pharmaceuticals S.L.. (11/22/16). "Press Release: Ability Pharmaceuticals Initiates Phase 2 Combination Trial with ABTL0812 as First Line Therapy in Patients with Endometrial or Squamous Lung Cancer". Barcelona. 2016-11-22
Ability Pharmaceuticals S.L.. (2/5/13). "Press Release: Ability Pharmaceuticals Awarded a 1.2 Million Euros Grant to Develop Its Lipid Analog ABTL0812 for Lung and Pancreatic Cancer. The Grant Will Fund the First-in-Man Phase Ib Clinical Trial". Bellater 2013-02-05
Ability Pharmaceuticals S.L.. (4/7/15). "Press Release: Ability Pharmaceuticals Receives Positive Opinion from EMA for Orphan Drug Status of ABTL0812 in Pediatric Cancer Neuroblastoma". Barcelona. 2015-04-07
Ability Pharmaceuticals S.L.. (9/18/17). "Press Release: Ability Pharmaceuticals Announces EMA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer". Barcelona. 2017-09-18
Ability Pharmaceuticals S.L.. (9/21/12). "Press Release: AB-Therapeutics Closes 1 Million Euro Financing Round and Changes the Company Name to Ability Pharmaceuticals". Bellaterra (Barcelona). 2012-09-21
Abingdon Health Ltd.. (10/13/14). "Press Release: Abingdon Health Ltd Acquires Serascience Ltd and Raises £2.1m from Shareholders". Birmingham. 2014-10-13
Abingdon Health Ltd.. (10/16/17). "Press Release: Abingdon Health and Skannex Sign a Co-marketing Agreement". 2017-10-16
Abingworth LLP. (1/21/16). "Press Release: Abingworth Raises $105m for First Dedicated Clinical Co-Development Fund". 2016-01-21
Abingworth LLP. (12/5/14). "Press Release: Abingworth Appoints Kurt von Emster as a Partner In Menlo Park". London. 2014-12-05
Abingworth LLP. (2/28/14). "Press Release: Abingworth Raises £225m ($375m) in Its Tenth Life Sciences Fund". London. 2014-02-28
Abingworth LLP. (7/10/14). "Press Release: Abingworth Promotes Ken Haas and Vin Miles to Partners". London. 2014-07-10
Abingworth LLP. (7/7/15). "Press Release: Abingworth Appoints Tim Haines and Kurt von Emster as Joint Managing Partners". London. 2015-07-07
Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London. 2018-07-09
Abingworth LLP. (9/16/16). "Press Release: GammaDelta Therapeutics Raises Seed Funding from Abingworth". 2016-09-16
Abionic S.A.. (3/28/18). "Press Release: Abionic Successfully Raises CHF20 Million in Series C Financing". Lausanne. 2018-03-28
Abionic S.A.. (9/13/19). "Press Release: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care". Lausanne. 2019-09-13
Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. 2019-09-05
Abionyx Pharma S.A.. (8/27/19). "Press Release: Change of Name and Stock Symbol/Mnemonic of Abionyx Pharma Shares (formerly Cerenis Therapeutics) as of August 29, 2019". Toulouse & Lakeland, US. 2019-08-27
Abionyx Pharma S.A.. (9/9/19). "Press Release: Cyrille Tupin Appointed CEO". Toulouse & Lakeland, US. 2019-09-09
Abivax S.A.. (1/29/18). "Press Release: Abivax Appoints Carol L. Brosgart, M.D. to Its Board of Directors". Paris. 2018-01-29
Abivax S.A.. (1/9/17). "Press Release: Abivax to Receive €8.4 Million from Bpifrance “Invest in the Future Program” (PIA) for the Development of Innovative Antiviral Drugs". Paris. 2017-01-09
Abivax S.A.. (10/30/14). "Press Release: Abivax Strengthens Executive Management Team with Senior Appointments Karl Birthistle, M.D., Appointed VP of Global Regulatory Affairs Daniel Kenny Appointed Chief Commercial Officer & VP of Business Development". 2014-10-30
Abivax S.A.. (11/12/15). "Press Release: Abivax to Participate in the Upcoming Jefferies Global Healthcare Conference in London and the German Equity Forum in Frankfurt". Paris. 2015-11-12
Abivax S.A.. (11/20/17). "Press Release: Abivax Enrolls First Ulcerative Colitis Patient in New ABX464 Proof-of-Concept Clinical Trial". Paris. 2017-11-20
Abivax S.A.. (12/15/16). "Press Release: Abivax Appoints Didier Blondel as Chief Financial Officer". Paris. 2016-12-15
next pagenext page 1 2 3 4 ... 170 171 172  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

» top